Please report any queries concerning the funding data grouped in the
sections named
"Externally Awarded"
or
"Internally Disbursed"
(shown on the profile page) to your Research Finance Administrator.
Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php
by entering your department
Please report any queries concerning the student data shown on the
profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Genetic Programming for Drug Discovery
-
Publication Type:Report
-
Authors:Langdon WB
-
publication date:26/02/2008
-
Place of publication:Wivenhoe Park, Colchester CO4 3SQ, UK
-
Report number:CES-481
-
Notes:keywords: genetic algorithms, genetic programming, Bioinformatics, GSK size: 16 pages
Abstract
Genetic programming \citekoza:book \citebanzhaf:1997:book \citelangdon:fogp is an established artificial intelligence technique which is used in many areas. Essentially it applies the older genetic algorithm technique \citeholland:book \citegoldberg:book to automatically generate programs. (See Figure 1.) The next section will introduce genetic programming, including a very short over view of the many areas where GP has been applied, before Section 4 concentrates on uses of genetic programming in the Pharmaceutical industry. We finish with a worked example (Section 5) which describes an evaluation of machine learning for predicting potential drugs’ activity with an pharmaceutically important enzyme (Human cytochrome P450 2D6) made by GlaxoSmithKline chemists \citelangdon:2001:wsc6, \citelangdon:2002:EuroGP, \citelangdon:2002:kdmdd, \citelangdon:2002:iberamia, \citehis02Plenary:Langdon, \citelangdon:2003:CEC. Appendix A gives pointers to further information.
› More
search options
There are no UCL People associated with
this publication